BioCatalyst

Upadacitinib — catalyst calendar

2 verified catalyst event(s) referencing Upadacitinib, each linked to its official source. Verified as of 2026-11-04.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01 (month)
in 2mo
ESTIMATED
 READOUT
Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids
Phase 3 · Atopic Dermatitis
 ABBV AbbVie Inc. Upadacitinib ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacit
Phase 3 · Systemic Lupus Erythematosus
 ABBV AbbVie Inc. Upadacitinib ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.